Provided By GlobeNewswire
Last update: Dec 11, 2025
Authorization Covers Multiple Screening Tests for Cancer and Chronic Disease Risk Detection
• Portfolio includes tests for colorectal disease, breast self exam, prostate disease, kidney disease, and H. pylori infection
Read more at globenewswire.comNASDAQ:BMRA (12/12/2025, 8:16:25 PM)
2.58
0 (0%)
Find more stocks in the Stock Screener


